CBD you can trust

CANNAPAN

Cannapan is the practitioner’s and patient’s trusted source of CBD (Cannabidiol). Scientist-formulated products paired with your doctor’s recommended dosage creates a safe and seamless experience.

#a1c584
#edbe65
#7f4aaa

WHAT WE DID

TRUSTED SOURCE FOR CBD

Cohort Clinical Science (CCS) is a nutraceutical company created by seasoned healthcare professionals to formulate and market products that are persistently monitored for real-world effectiveness and safety. CCS’s products are uniquely distributed via physician / practitioner-linked channels; creating an intelligent ecosystem for product access and evidence-informed use. CCS’s first product brand is Cannapan for Pain & Inflammation.

SEE WHAT THEY’RE ABOUT

THE BRIEF

Cannabidiol (CBD) is a naturally occurring compound found in the resinous flower of cannabis and has extensive health benefits. The issue is that the industry is plagued with bad players trying to take advantage of its rising popularity for a profit. Cannapan’s mission is to bring a standard to the space of CBD by creating a closed doctor patient network coined as pCommerce that will allow research to help doctors assess how much CBD a patient should take. The goal is to have pCommerce create a standardized and safe product in the space.

The end product of Cannapan will be the standard for health and research for CBD.

Formulated by scientists. Recommended by Doctors.

THE SOLUTION

To advance the science of medical grade CBD as an alternative pain management therapy. CXN was tasked with three key goals. Creating evidence-based research to leverage physician distribution channel. Communities of interests to improve patient engagement. Communities of practice to share best practices and patient’s outcomes.

CXN created waiting room activations across the doctor network to drive product awareness and patient acquisition.

THE RESULTS

CXN created science-informed products through the Unite Program – an intelligent physician/patient supply chain termed “pCommerce” that delivers unique and targeted products based on real-world health outcomes and safety monitoring through Cohort Clinical Sciences’ partner epidemiology, and risk-monitoring team.

$1M+

FUNDRAISED

DEVELOPMENT

STRATEGY

ACQUISITION

"CXN Collective has played a monumental role in the curation and execution of our business model since inception. Without them we wouldn’t have been this far along in such a short time."

GREG PAULUS CEO of Cohort CS and Managing Partner of Plexus Healthcare

OTHER WORK YOU'LL LOVE

LET’S START YOUR PROJECT